In briefBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7496.862 (Published 14 April 2005) Cite this as: BMJ 2005;330:862
Cheap, fixed dose treatment is planned for malaria: The Drugs for Neglected Diseases Initiative (a non-profit drug development organisation) and Sanofi-Aventis have agreed to develop a new, fixed dose combination of artemisinin based compound to treat falciparum malaria in Africa. The target price of the treatment is less than $1 (£0.53; €0.77) for a three day course.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial